NexImmune | 10-K: Annual report
Apr 16 16:12 ET
NexImmune | 3: Initial statement of beneficial ownership of securities-Officer Marchio Albert N II
Apr 10 17:18 ET
NexImmune | 8-K: Current report
Apr 5 16:10 ET
NexImmune | NT 10-K: Others
Mar 29 16:09 ET
NexImmune | DEFA14A: Others
Feb 6 16:34 ET
NexImmune | 8-K: Current report
Feb 5 17:15 ET
NexImmune | 424B5: Prospectus
Feb 5 16:41 ET
NexImmune | 8-K: Current report
Feb 2 13:31 ET
NexImmune | 8-K: Current report
Feb 1 09:21 ET
NexImmune | 8-K: Current report
Jan 19 00:00 ET
NexImmune | DEFA14A: Others
Jan 18 00:00 ET
NexImmune | 8-K: Current report
Dec 22, 2023 16:01 ET
NexImmune | 8-K: Current report
Dec 1, 2023 13:39 ET
NexImmune | 144/A: Others
Nov 22, 2023 17:40 ET
NexImmune | 144/A: Others
Nov 22, 2023 17:34 ET
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Roemer Alan S.
Nov 22, 2023 17:18 ET
NexImmune | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 21, 2023 16:39 ET
NexImmune | DEF 14A: Definitive information statements
Nov 20, 2023 17:19 ET
NexImmune | 8-K/A: Current report (Amendment)
Nov 20, 2023 17:01 ET
NexImmune: Q3 2023 Earnings Report
Nov 17, 2023 16:03 ET
No Data
No Data